Toxicity of neoadjuvant intraperitoneal and systemic chemotherapy in gastric cancer with peritoneal dissemination

被引:0
|
作者
Munoz Martin, A. [1 ]
Garcia Alfonso, P. [1 ]
Martinez Marin, V. [1 ]
Gonzalez Bayon, L. [1 ]
Gonzalez Moreno, S. [2 ]
Torres Melero, J. [3 ]
Reche, P. [3 ]
Jerez Gilarranz, Y. [1 ]
Cabezon Gutierrez, L. [1 ]
del Val Subirats, R. Gonzalez [1 ]
机构
[1] Hosp Gen Gregorio Maranon, Madrid, Spain
[2] MD Anderson Madrid, Madrid, Spain
[3] Hosp Torrecardenas, Almeria, Spain
来源
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词
D O I
10.1016/S1359-6349(09)71273-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:376 / 376
页数:1
相关论文
共 50 条
  • [41] Clinical Significance of Cytological Status of Peritoneal Lavage Fluid During Intraperitoneal Chemotherapy for Gastric Cancer with Overt Peritoneal Dissemination
    Shigenobu Emoto
    Joji Kitayama
    Hironori Ishigami
    Hironori Yamaguchi
    Toshiaki Watanabe
    Annals of Surgical Oncology, 2015, 22 : 780 - 786
  • [42] Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis
    Tajik, Fatemeh
    Eyob, Belain
    Khan, Aaqil M.
    Radhakrishnan, Vinodh Kumar
    Senthil, Maheswari
    CANCERS, 2025, 17 (02)
  • [43] Intraperitoneal chemotherapy for gastric cancer with peritoneal dissemination: A single center retrospective analysis of 82 cases.
    Yoshida, Masahiro
    Tsuji, Yasushi
    Oiwa, Syutaro
    Takayama, Toshizo
    Okamura, Naoka
    Sugiyama, Junko
    Sumiyoshi, Tetsuya
    Hirayama, Michiaki
    Kondo, Hitoshi
    Okushiba, Syunichi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [44] Feasibility Study of S-1 and Intraperitoneal Docetaxel Combination Chemotherapy for Gastric Cancer with Peritoneal Dissemination
    Fujiwara, Yoshiyuki
    Nishida, Toshiro
    Takiguchi, Shuji
    Nakajima, Kiyokazu
    Miyata, Hiroshi
    Yamasaki, Makoto
    Yamamoto, Kazuyoshi
    Moon, Jeong-Ho
    Mori, Masaki
    Doki, Yuichiro
    ANTICANCER RESEARCH, 2010, 30 (04) : 1335 - 1339
  • [45] Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study
    Yu, Pengfei
    Ye, Zeyao
    Dai, Gaiguo
    Zhang, Yanqiang
    Huang, Ling
    Du, Yian
    Cheng, Xiangdong
    BMC CANCER, 2020, 20 (01)
  • [46] Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study
    Pengfei Yu
    Zeyao Ye
    Gaiguo Dai
    Yanqiang Zhang
    Ling Huang
    Yian Du
    Xiangdong Cheng
    BMC Cancer, 20
  • [47] Neoadjuvant systemic chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis from colorectal cancer
    Asher, N.
    Lahat, G.
    Geva, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
    Sakamoto, Shuichi
    Kagawa, Shunsuke
    Kuwada, Kazuya
    Ito, Atene
    Kajioka, Hiroki
    Kakiuchi, Yoshihiko
    Watanabe, Megumi
    Kagawa, Tetsuya
    Yoshida, Ryuichi
    Kikuchi, Satoru
    Kuroda, Shinji
    Tazawa, Hiroshi
    Fujiwara, Toshiyoshi
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [49] S-1 and intraperitoneal and intravenous paclitaxel as neoadjuvant chemotherapy for gastric cancer with positive peritoneal cytology
    Peng, Y.
    Imano, M.
    Imamoto, H.
    Nishiki, K.
    Nakamori, Y.
    Shiraishi, O.
    Yasuda, A.
    Shinkai, M.
    Yasuda, T.
    Shiozaki, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [50] Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis
    Kim, Dong-Wook
    Jee, Ye Seob
    Kim, Chang Hyun
    Kim, Jin-Jo
    Park, Sungsoo
    Choi, Sung Il
    Park, Joong-M In
    Kim, Jong-Han
    JOURNAL OF GASTRIC CANCER, 2020, 20 (01) : 50 - 59